Journal of Urban Health

, Volume 77, Issue 3, pp 369–382 | Cite as

Changes in injection risk behavior associated with participation in the seattle needle-exchange program

Original Articles: Substance Use and HIV Prevention

Abstract

We studied the influence of the Seattle, Washington, needle-exchange program on sharing of drug injection equipment (syringes, drug cookers, filtration cotton) to identify potential gaps in risk reduction and to understand in greater detail the lack of an association between exchange use and risk of hepatitis B or C virus transmission. In a cohort of 2,208 injection drug users who completed a 1-year follow-up visit, we measured the association between needle-exchange use at study enrollment (ever vs. never) and injection risk behavior at the follow-up. Control for confounding was carried out using both logistic regression and propensity score analytic methods to estimate the adjusted odds ratio (AOR). In both univariate and multivariate analyses ,needle-exchange use was associated with a lower likelihood of injection with a used syringe (AOR-0.7,95% confidence limit 0.5,0.9). There was no association between exchange use and cooker or cotton sharing (AOR-0.8,95% confidence limit 0.6, 1.1) or between exchange use and use of a common syringe to divide drugs (AOR=0.9). This analysis suggests that risk reduction measures adopted by users of the Seattle exchange may not be sufficient to prevent transmission of all blood-borne viruses, including hepatitis C virus. Creater awareness of the infection risk associated with these practices may help curb this type of equipment sharing and ultimately prevent disease transmission.

Key words

Behavior Change HBV HCV HIV Injection Drug Use Needle-Exchange Program Prevention Substance Abuse Syringe-Exchange Program 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Paone D, Clark J, Shi Q, Purchase D, Des Jarlais DC. Syringe exchange in the Unied States, 1996: a National Profile.Am J Public Health. 1999;89:43–46.PubMedGoogle Scholar
  2. 2.
    Ball AL, Rana S, Dehne KL. HIV prevention among injecting drug users: responses in developing and transitional countries.Public Health Rep. 1998;113(suppl):170–181.PubMedGoogle Scholar
  3. 3.
    Donoghoe MC, Stimson GV, Dolan K, Aldritt L. Changes in HIV risk behavior in clients of syringe-exchange schemes in England and Scotland.AIDS. 1989;3:267–272.PubMedGoogle Scholar
  4. 4.
    Hagan H, Des Jarlais DC, Purchase D, Friedman SR, Reid TR, Bell TA. An interview study of participants in the Tacoma, Washington, syringe exchange.Addiction. 1993; 88:1691–1697.CrossRefPubMedGoogle Scholar
  5. 5.
    Schoenbaum EE, Hartel DM, Gourevitch MN. Needle exchange use among a cohort of injecting drug users.AIDS. 1996;10:1729–1734.PubMedGoogle Scholar
  6. 6.
    Vlahov D, Junge B. The role of needle exchange programs in HIV prevention.Public Health Rep. 1998;113(suppl):75–80.PubMedGoogle Scholar
  7. 7.
    Bluthenthal RN, Kral AH, Erringer EA, Edlin BR. Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995.J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18:505–511.PubMedGoogle Scholar
  8. 8.
    MacGowan RJ, Sterk CE, Long A, Cheney R, Seeman M, Anderson JE. New needle and syringe use, and use of needle exchange programmes by street recruited injection drug users in 1993.Int J Epidemiol. 1998;27:302–308.CrossRefPubMedGoogle Scholar
  9. 9.
    Normand J, Vlahov D, Moses LE, eds.Preventing HIV Transmission: the Role of Sterile Needles and Bleach. Washington, DC: National Academy Press; 1995.Google Scholar
  10. 10.
    Watters J, Estilo MJ, Clark GL, Lorvick J. Syringe and needle exchange as HIV/AIDS prevention for injection drug users.JAMA. 1994;271:115–120.CrossRefPubMedGoogle Scholar
  11. 11.
    Des Jarlais DC, Marmor M, Paone D et al. HIV incidence among injecting drug users in New York City syringe exchange programmes.Lancet. 1996;348:987–991.CrossRefPubMedGoogle Scholar
  12. 12.
    Hagan H, Des Jarlais DC, Friedman SR, et al. Reduced risk of hepatitis B and hepatitis C associated with participation in the Tacoma syringe exchange.Am J Public Health 1995;85:1531–1537.PubMedGoogle Scholar
  13. 13.
    Hurley S, Jolley DJ, Kaldor JM. Effectiveness of needle-exchange programmes for prevention of HIV infection.Lancet. 1997;349:1797–1800.CrossRefPubMedGoogle Scholar
  14. 14.
    Kaplan EH, Heimer R. A circulation theory of needle exchange.AIDS. 1994;8:567–574.PubMedGoogle Scholar
  15. 15.
    Strathdee SA, Patrick DM, Currie S et al. Needle exchange is not enough: lessons from the Vancouver injection drug use study.AIDS. 1997;11:F59-F65.CrossRefPubMedGoogle Scholar
  16. 16.
    Bruneau J, Lamothe F, Franco E, et al. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study.Am J Epidemiol. 1997;146:994–1002.PubMedGoogle Scholar
  17. 17.
    Hagan H, McGrough JP, Thiede H, Weiss NS, Hopkins S, Alexander ER. Syringe exchange and risk of hepatitis B and C viruses.Am J Epidemiol. 1999;149:203–213.PubMedGoogle Scholar
  18. 18.
    Schechter MT, Strathdee SA, Cornelisse PG, et al. Do needle exchange programmes increase the spread of HIV among injection drug users? An investigation of the Vancouver outbreak.AIDS. 1999;13:F45-F51.CrossRefPubMedGoogle Scholar
  19. 19.
    Hagan H, Thiede H, Weiss NS, Hopkins S, Alexander ER. Volunteer bias in nonrandomized evaluations of the efficacy of needle exchange programs.J Urban Health. 2000;77:93–102.CrossRefGoogle Scholar
  20. 20.
    D'Agostino RB. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.Stat Med. 1998;17:2265–2281.PubMedGoogle Scholar
  21. 21.
    Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score.J Am Stat Assoc. 1984;79:516–524.Google Scholar
  22. 22.
    Cochran WG. The effectiveness of adjustment by subclassification in removing bias in observational studies.Biometrics. 1968;24:295–313.PubMedGoogle Scholar
  23. 23.
    Paone D, Clark J, Shi Q, Purchase D, Des Jarlais DC. Syringe exchange in the United States 1996: a national profile.Am J Public Health. 1999;89:43–46.PubMedGoogle Scholar
  24. 24.
    Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease.J Natl Cancer Inst. 1959;22:719–748.PubMedGoogle Scholar
  25. 25.
    Crofts N, Aitken CK. Incidence of blood-borne virus infection and risk behaviors in a cohort of injecting drug users in Victoria, 1990–1995.Med J Aus. 1997;167:17–20.Google Scholar
  26. 26.
    Hunter GM, Donoghoe MC, Stimson GV, Rhodes T, Chalmers CP. Changes in the injecting risk behavior of injecting drug users in London, 1990–1993.AIDS. 1995;9:493–501.PubMedGoogle Scholar
  27. 27.
    McCoy CB, Metsch LR, Chirwood DD, Shapshak P, Comersford ST. Parenteral transmission of HIV among injection drug users: assessing the frequency of multiperson use of needles, syringes, cookers, cotton and water.J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(suppl 1):S25-S29.PubMedGoogle Scholar
  28. 28.
    Hagan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER. Sharing of drug preparation equipment as a risk factor for hepatitis C virus incidence.Am J Public Health. In press. 2000.Google Scholar
  29. 29.
    Gerberding JL. Management of occupational exposures to blood-borne viruses.New Engl J Med. 1995;332:444–451.CrossRefPubMedGoogle Scholar
  30. 30.
    Tortu S, Deren D, Beardsley M, Hamid R. Factors associated with needle exchange use in East Harlem, New York City.J Drug Issues. 1996;26:735–749.Google Scholar

Copyright information

© The New York Academy of Medicine 2000

Authors and Affiliations

  1. 1.University of Washington, Department of EpidemiologyUSA
  2. 2.Public Health-Seattle and King CountySeattle

Personalised recommendations